Jeffrey J Jackson

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Venues

Journal of medicinal chemistry

PLoS pathogens

This page only lists publications with an associated author ORCID identifier.

Publications

Jeffrey J Jackson, Aaron C Siegmund, Wen-Ju Bai, Anthony B Reed, Adam B Birkholz, Iain D G Campuzano, Amandine Créquer-Grandhomme, Ruozhen Hu, Rucha V Modak, Athena Sudom, Noelle Javier, Christiana Sanders, Mei-Chu Lo, Fang Xie, Victor J Cee, Paolo Manzanillo, John G Allen
Imidazolone as an Amide Bioisostere in the Development of β-1,3- N -Acetylglucosaminyltransferase 2 (B3GNT2) Inhibitors. Journal of medicinal chemistry (2023)
Jeffrey J Jackson, Grant M Shibuya, Buvana Ravishankar, Lavanya Adusumilli, Delia Bradford, Dirk G Brockstedt, Cyril Bucher, Minna Bui, Cynthia Cho, Christoph Colas, Gene Cutler, Adrian Dukes, Xinping Han, Dennis X Hu, Scott Jacobson, Paul D Kassner, George E Katibah, Michelle Yoo Min Ko, Urvi Kolhatkar, Paul R Leger, Anqi Ma, Lisa Marshall, Jack Maung, Andrew A Ng, Akinori Okano, Deepa Pookot, Daniel Poon, Chandru Ramana, Maureen K Reilly, Omar Robles, Jacob B Schwarz, Anton A Shakhmin, Hunter P Shunatona, Raashi Sreenivasan, Parcharee Tivitmahaisoon, Mengshu Xu, Thant Zaw, David J Wustrow, Mikhail Zibinsky
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis Therapy. Journal of medicinal chemistry 65 (19) (2022)
Aparna Jorapur, Lisa A Marshall, Scott Jacobson, Mengshu Xu, Sachie Marubayashi, Mikhail Zibinsky, Dennis X Hu, Omar Robles, Jeffrey J Jackson, Valentin Baloche, Pierre Busson, David Wustrow, Oezcan Talay, Oezcan Talay, Paul D Kassner, Gene Cutler
EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22. PLoS pathogens 18 (1) (2022)
Omar Robles, Jeffrey J Jackson, Lisa Marshall, Oezcan Talay, David Chian, Gene Cutler, Raymond Diokno, Dennis X Hu, Scott Jacobson, Emily Karbarz, Paul D Kassner, John M Ketcham, Jenny McKinnell, Cesar Meleza, Maureen K Reilly, Erin Riegler, Hunter P Shunatona, Angela Wadsworth, Ashkaan Younai, Dirk G Brockstedt, David J Wustrow, Mikhail Zibinsky
Novel Piperidinyl-Azetidines as Potent and Selective CCR4 Antagonists Elicit Antitumor Response as a Single Agent and in Combination with Checkpoint Inhibitors. Journal of medicinal chemistry 63 (15) (2020)
Jeffrey J Jackson, John M Ketcham, Ashkaan Younai, Betty Abraham, Berenger Biannic, Hilary P Beck, Minna H T Bui, David Chian, Gene Cutler, Raymond Diokno, Dennis X Hu, Scott Jacobson, Emily Karbarz, Paul D Kassner, Lisa Marshall, Jenny McKinnell, Cesar Meleza, Abood Okal, Deepa Pookot, Maureen K Reilly, Omar Robles, Hunter P Shunatona, Oezcan Talay, James R Walker, Angela Wadsworth, David J Wustrow, Mikhail Zibinsky
Discovery of a Potent and Selective CCR4 Antagonist That Inhibits Treg Trafficking into the Tumor Microenvironment. Journal of medicinal chemistry 62 (13) (2019)

Jeffrey J Jackson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jeffrey J Jackson